ADIPOQ and Insulin resistance: The reason for this is that obesity and T2D can result from adiponectin deficiency, thus making this hormone a good target for possible therapeutic interventions, focusing on the possibility that adiponectin treatment may improve T2D and obesity-related insulin resistance [11].